41 results
Page 2 of 3
S-3ASR
8q1osmz vwxxbeuto2
23 Sep 22
Automatic shelf registration
4:08pm
8-K
EX-1.1
5nh 5pfzhpw9jgmavg
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
424B5
zxelhjlot
21 Jul 22
Prospectus supplement for primary offering
4:43pm
424B5
kmqqb
20 Jul 22
Prospectus supplement for primary offering
4:22pm
S-3
EX-1.2
23me waz4
1 Jul 22
Shelf registration
4:36pm
S-3
vhl s6jyqhzl7sigzmb
1 Jul 22
Shelf registration
4:36pm
DEF 14A
mf3cple6aumawg hk
29 Apr 22
Definitive proxy
7:01am
10-K
554kd
14 Mar 22
Annual report
7:04am
8-K
EX-99.1
jbsl524
10 Nov 21
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2021 Financial Results
6:56am
10-Q
tdz85vr
12 Aug 21
Quarterly report
8:53am
424B4
jzf77
17 Jun 21
Prospectus supplement with pricing info
4:50pm
S-1/A
EX-1.1
ublg4468wov kf461
14 Jun 21
IPO registration (amended)
6:15am
S-1/A
b3pedncf n3i3w9dfdfj
14 Jun 21
IPO registration (amended)
6:15am
S-1
0mpwlorf
28 May 21
IPO registration
4:04pm
S-1
EX-10.1
gatadzpy0b4f13i6
28 May 21
IPO registration
4:04pm
DRS
w5d4rzdj3hm5qjcc
16 Apr 21
Draft registration statement
12:00am